Olivier Gaide Selected Research

Olivier Gaide Research Topics

Disease

9	Neoplasms (Cancer) 03/2021 - 05/2008
5	Ectodermal Dysplasia (Aplasia Cutis Congenita) 02/2014 - 11/2007
4	Contact Dermatitis (Eczema, Contact) 01/2017 - 08/2007
3	Melanoma (Melanoma, Malignant) 01/2021 - 10/2014
3	Skin Neoplasms (Skin Cancer) 01/2021 - 10/2007
3	Infections 01/2012 - 11/2007
3	Anhidrotic Ectodermal Dysplasia 1 10/2009 - 11/2007
2	Basal Cell Carcinoma (Rodent Ulcer) 01/2021 - 11/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 10/2014
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 02/2013 - 10/2007
1	Lymphoma (Lymphomas) 01/2022
1	Neoplasm Metastasis (Metastasis) 03/2021
1	Dermatofibrosarcoma 04/2020
1	Sarcoma (Soft Tissue Sarcoma) 04/2020
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 03/2016
1	Mycosis Fungoides 03/2016
1	Actinic Keratosis 01/2016
1	Inflammation (Inflammations) 01/2016
1	Conjunctivitis 01/2016
1	Bites and Stings (Sting) 12/2015
1	Colonic Neoplasms (Colon Cancer) 12/2015
1	Gastritis 12/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2014
1	Keratoacanthoma 10/2014
1	Burnett Schwartz Berberian syndrome 10/2014
1	Fatigue 10/2014
1	Pain (Aches) 04/2014
1	Atopic Dermatitis (Atopic Eczema) 12/2013
1	Asthma (Bronchial Asthma) 12/2013
1	Hypotrichosis 09/2009
1	Sezary Syndrome (Sezary Erythroderma) 05/2008
1	Gout 01/2008
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2007
1	Eczema 08/2007
1	Necrosis 10/2004

Drug/Important Bio-Agent (IBA)

4	EctodysplasinsIBA 02/2014 - 10/2004
3	InflammasomesIBA 12/2013 - 08/2007
2	AntibodiesIBA 02/2014 - 09/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013 - 05/2008
2	LigandsIBA 10/2009 - 05/2008
2	Death Domain ReceptorsIBA 05/2008 - 10/2007
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	IntegrinsIBA 11/2018
1	Fibronectins (Fibronectin)IBA 11/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2018
1	Collagen Type XVIIIBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	DinitrofluorobenzeneIBA 01/2017
1	3-ingenyl angelateIBA 01/2016
1	SteroidsIBA 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	Fusidic Acid (Fucithalmic)IBA 01/2016
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2015
1	Adenosine Monophosphate (AMP)IBA 12/2015
1	DNA (Deoxyribonucleic Acid)IBA 12/2015
1	Immunoglobulin E (IgE)IBA 12/2014
1	Immunoglobulin G (IgG)IBA 12/2014
1	Pharmaceutical PreparationsIBA 12/2014
1	Peptide Hydrolases (Proteases)FDA Link 12/2014
1	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 12/2014
1	VemurafenibIBA 10/2014
1	trametinibIBA 10/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2014
1	Mitogen-Activated Protein KinasesIBA 10/2014
1	dabrafenibIBA 10/2014
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2014
1	Monoclonal AntibodiesIBA 02/2014
1	Blocking AntibodiesIBA 02/2014
1	CytokinesIBA 12/2013
1	Interleukin-1 (Interleukin 1)IBA 12/2013
1	Thymic Stromal LymphopoietinIBA 12/2013
1	Biological ProductsIBA 08/2013
1	TNF-Related Apoptosis-Inducing LigandIBA 03/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2013
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2012
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 09/2009
1	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 05/2008
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 05/2008
1	chlorobenzeneIBA 08/2007
1	Edar ReceptorIBA 10/2004

Therapy/Procedure

5	Therapeutics 03/2016 - 09/2009
2	Radiotherapy 01/2022 - 10/2019
2	Immunotherapy 03/2021 - 12/2015
1	Transplantation 01/2021
1	Organ Transplantation 01/2021
1	Operative Surgical Procedures 04/2020
1	Immunomodulation 12/2014